DeepMed Research

Peking University First Hospital (Peking Univesity First Medical School)

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Multimodalitic Imaging in the N-stage of Lung Cancer

Not Applicable

Not yet recruiting

Conditions: Neoplasm of Lung

Interventions: Drug: 18F-FDG
Procedure: EBUS-TBNA
Device: MR STIR

First Posted Date: 2023-05-03

Last Posted Date: 2023-05-03

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 100

Registration Number: NCT05840094

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Digital Cognitive Behavioral Therapy for Insomnia for Chronic Insomnia in Breast Cancer Survivors

Not Applicable

Recruiting

Conditions: Chronic Insomnia

Interventions: Behavioral: Digital Cognitive Behavioral Therapy for Insomnia

First Posted Date: 2023-04-14

Last Posted Date: 2024-10-22

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 264

Registration Number: NCT05813392

Locations: 🇨🇳
Jing Ma, Beijing, Beijing, China

Effect of Patent Hemostatic Device (PHD) With Quantitative Pressure on Radial Artery Hemostasis After CAG/PCI

Not Applicable

Recruiting

Conditions: Percutaneous Coronary Intervention
Hemostasis

Interventions: Device: Control group with TR-Band
Device: Intervention group with PHD-Band

First Posted Date: 2023-03-30

Last Posted Date: 2024-07-11

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 200

Registration Number: NCT05790603

Locations: 🇨🇳
Xuanwu Hospital, Beijing, Beijing, China
🇨🇳
Peking University First Hospital, Beijing, China

Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II

Not yet recruiting

Conditions: NOACs
Pharmacodynamics
Rivaroxaban
RNA Profile
Bleeding
Apixaban
Dabigatran
Pharmacogenomics
Novel Oral Anticoagulants
Edoxaban

Interventions: Genetic: Detection of genotype and RNA profile in platelet and white blood cell
Other: Indicators test related to platelet function
Other: Indicators test related to coagulation function

First Posted Date: 2023-03-10

Last Posted Date: 2023-03-10

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 2000

Registration Number: NCT05764356

Locations: 🇨🇳
Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China
🇨🇳
Anhui Provincial Hospital#The First Affiliated Hospital Of USTC#, Hefei, Anhui, China
🇨🇳
The Second Affiliated Hospital Of Chongqing Medical University, Chongqing, Chongqing, China

and more 3 locations

A Clinical Study of Fundus OCTA for the Identification of CMD

Recruiting

Conditions: Coronary Microvascular Disease

Interventions: Diagnostic Test: CaIMR

First Posted Date: 2023-02-24

Last Posted Date: 2024-11-11

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 400

Registration Number: NCT05743140

Locations: 🇨🇳
Peking university first hospital, Beijing, Beijing, China

Dexmedetomidine-esketamine Combined Nasal Administration and Perioperative Sleep Quality

Phase 4

Recruiting

Conditions: Perioperative Period
Dexmedetomidine
Breast Cancer
Esketamine
Sleep Quality

Interventions: Drug: Normal saline
Drug: Dexmedetomidine
Drug: Esketamine

First Posted Date: 2023-02-16

Last Posted Date: 2023-05-25

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 180

Registration Number: NCT05732064

Locations: 🇨🇳
Peking University First Hospital, Beijin, Bejing, China

Fractional Flow Reserve to Determine Atherosclerosis Renovascular Hypertension Stenting

Not Applicable

Recruiting

Conditions: Renal Artery Stenosis Atherosclerotic
Secondary Hypertension Renal Arterial

Interventions: Drug: Dopamine
Diagnostic Test: Fractional Flow Reserve, Renal
Device: Renal artery stenting

First Posted Date: 2023-02-16

Last Posted Date: 2024-06-06

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 100

Registration Number: NCT05732077

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
🇨🇳
Beijing Anzhen Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳
The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

and more 10 locations

Night-time Dexmedetomidine-esketamine Infusion and Sleep Quality With Mechanical Ventilation

Phase 4

Recruiting

Conditions: Intensive Care Unit
Mechanical Ventilation
Dexmedetomidine
Esketamine
Sleep Quality

Interventions: Drug: Dexmedetomidine-esketamine
Drug: Propofol-remifentanil

First Posted Date: 2023-02-08

Last Posted Date: 2024-02-29

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 174

Registration Number: NCT05718024

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Mini-dose Esketamine-dexmedetomidine Supplemented Analgesia and Long-term Outcomes

Phase 4

Active, not recruiting

Conditions: Esketamine
Chronic Postsurgical Pain
Scoliosis Correction
Postoperative Analgesia
Dexmedetomidine

Interventions: Drug: Esketamine
Drug: Dexmedetomidine
Drug: Sufentanil

First Posted Date: 2023-02-08

Last Posted Date: 2023-02-09

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 199

Registration Number: NCT05718544

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome

Phase 4

Recruiting

Conditions: Semaglutide
PCOS (Polycystic Ovary Syndrome)

Interventions: Drug: Semaglutide, 1.34 mg/mL
Drug: Semaglutide, 1.34 mg/mL and Metformin Hydrochloride 500 MG
Drug: Metformin Hydrochloride 500 MG
Behavioral: calorie-restricted diet
Behavioral: physical exercise

First Posted Date: 2023-01-27

Last Posted Date: 2024-03-25

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 75

Registration Number: NCT05702905

Locations: 🇨🇳
PekingUFH, Peking, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy